ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 39606239

Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies.

Ma Y and 3 others. Front Immunol, 2024. Cited by 17 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies. Papers, record 39606239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39606239

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies.
PubMed
Journal
Front Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
2.25, provisional
iCite
Revised in PubMed
2026-09-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ma YYuanchun
2Sun YYing
3Guo HHongqian
4Yang RRong

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Urinary Bladder NeoplasmsMajor topic
Tumor-Associated MacrophagesMajor topic
Humans
Animals
Tumor Microenvironment
Molecular Targeted Therapy
Immunotherapy
Prognosis
Neoplasm Staging

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References127

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116,397,056CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer.Clin Cancer Res2006https://conductscience.org/library/papers/16397056PubMed
224,812,208The cellular and molecular origin of tumor-associated macrophages.Science2014https://conductscience.org/library/papers/24812208PubMed
326,759,009Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancer.Cancer Immunol Immunother2016https://conductscience.org/library/papers/26759009PubMed
433,236,624Intravesical In Situ Immunostimulatory Gel for Triple Therapy of Bladder Cancer.ACS Appl Mater Interfaces2020https://conductscience.org/library/papers/33236624PubMed
518,448,973Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs.Curr Opin Infect Dis2008https://conductscience.org/library/papers/18448973PubMed
627,729,991Role of angiogenesis in urothelial bladder carcinoma.Cent European J Urol2016https://conductscience.org/library/papers/27729991PubMed
733,747,932Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome.Front Oncol2021https://conductscience.org/library/papers/33747932PubMed
831,530,560Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia.Cancer Immunol Res2019https://conductscience.org/library/papers/31530560PubMed
927,345,655Bladder cancer.Lancet2016https://conductscience.org/library/papers/27345655PubMed
109,698,673Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer.Br J Urol1998https://conductscience.org/library/papers/9698673PubMed

1 to 10 of 127

See all 127 references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42,984,715Overexpression of TUBA1A suppresses bladder cancer progression with potential modulation of autophagic activity and macrophage polarization.Front Immunol2026https://conductscience.org/library/papers/42984715PubMed
42,410,370FZD5 drives macrophage-mediated immunomodulation and predicts prognosis in glioma: evidence from single-cell sequencing.BMC Cancer2026https://conductscience.org/library/papers/42410370PubMed
42,319,469Single-cell transcriptomics identifies key immune-suppressive cells and their driver genes in the bladder cancer microenvironment with prognostic implications.Mol Genet Genomics2026https://conductscience.org/library/papers/42319469PubMed
41,943,838Metabolic-Immune Coupling in Urologic Cancers: Macrophage Reprogramming as a Therapeutic Nexus.Int J Biol Sci2026https://conductscience.org/library/papers/41943838PubMed
41,850,821Histopathological Basis of Peritumoral Enhancement in Muscle-invasive Bladder Cancer.Magn Reson Med Sci2026https://conductscience.org/library/papers/41850821PubMed
41,616,005Resveratrol inhibits bladder cancer proliferation by targeting the AURKA/STAT3 axis: From computational analysis to experimental validation.PLoS One2026https://conductscience.org/library/papers/41616005PubMed
41,557,096Exosomal crosstalk between breast cancer cells and tumor-associated macrophages: mechanisms and therapeutic implications.Mol Biol Rep2026https://conductscience.org/library/papers/41557096PubMed
41,403,926The significance of trained immunity in cancer.Front Immunol2025https://conductscience.org/library/papers/41403926PubMed
41,296,173Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets.Genes Genomics2026https://conductscience.org/library/papers/41296173PubMed
41,288,679Epigenetic programming of macrophages across inflammatory and malignant diseases.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41288679PubMed

1 to 10 of 14

See all 14 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39606239

GET https://conductscience.org/api/papers/v1/39606239/references?page=2

API referenceFor AI assistants